Cardiovascular Health and COVID-19
Submission Deadline: 30 Jul 2022
Guest Editor
Special Issue Information
Dear Colleagues,
Several studies have shown that patients with existing cardiovascular diseases who develop SARS-CoV-2 infections have a poor prognosis; especially those presenting with an acute myocardial injury, in whom mortality is increased. In addition, existing coronary artery disease is a significant risk factor for acute myocardial infarction among patients with SARS-CoV-2 infection. The COVID-19 pandemic has made it more difficult for cardiovascular physicians to deliver optimal care for heart patients, and there have been delays in treatment. There is also a concern regarding the long-term effects of the COVID-19 pandemic in patients with and those that develop cardiovascular diseases, which may contribute to increased morbidity and mortality. The role of prevention, including effective cholesterol lowering medication, is essential. In addition, the role of ACE2 receptors and endothelial dysfunction is under intensive investigation to determine the vascular pathogenesis of the SARS-CoV-2 infection.
This Special Issue welcomes original research articles, opinion articles and reviews related to all aspects of cardiovascular health and COVID-19.
Prof. Dr. Alpo Vuorio
Guest Editor
Keywords
- COVID-19
- SARS-CoV-2
- Acute myocardial injury
- Coronary artery disease
- Cardiovascular disease
- ACE2
- Endothelial dysfunction
Manuscript Submission Information
Manuscripts should be submitted via our online editorial system at https://imr.propub.com by registering and logging in to this website. Once you are registered, click here to start your submission. Manuscripts can be submitted now or up until the deadline. All papers will go through peer-review process. Accepted papers will be published in the journal (as soon as accepted) and meanwhile listed together on the special issue website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts will be thoroughly refereed through a double-blind peer-review process. Please visit the Instruction for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted manuscripts should be well formatted in good English.
Published Papers (9)
Rev. Cardiovasc. Med. 2023, 24(2), 54; https://doi.org/10.31083/j.rcm2402054
(This article belongs to the Special Issue Cardiovascular Health and COVID-19)
Rev. Cardiovasc. Med. 2022, 23(12), 410; https://doi.org/10.31083/j.rcm2312410
(This article belongs to the Special Issue Cardiovascular Health and COVID-19)
Rev. Cardiovasc. Med. 2022, 23(12), 404; https://doi.org/10.31083/j.rcm2312404
(This article belongs to the Special Issue Cardiovascular Health and COVID-19)
Rev. Cardiovasc. Med. 2022, 23(11), 362; https://doi.org/10.31083/j.rcm2311362
(This article belongs to the Special Issue Cardiovascular Health and COVID-19)
Rev. Cardiovasc. Med. 2022, 23(10), 339; https://doi.org/10.31083/j.rcm2310339
(This article belongs to the Special Issue Cardiovascular Health and COVID-19)
Rev. Cardiovasc. Med. 2022, 23(9), 292; https://doi.org/10.31083/j.rcm2309292
(This article belongs to the Special Issue Cardiovascular Health and COVID-19)
Rev. Cardiovasc. Med. 2022, 23(5), 182; https://doi.org/10.31083/j.rcm2305182
(This article belongs to the Special Issue Cardiovascular Health and COVID-19)
Rev. Cardiovasc. Med. 2022, 23(2), 50; https://doi.org/10.31083/j.rcm2302050
(This article belongs to the Special Issue Cardiovascular Health and COVID-19)
Rev. Cardiovasc. Med. 2021, 22(4), 1685-1691; https://doi.org/10.31083/j.rcm2204176
(This article belongs to the Special Issue Cardiovascular Health and COVID-19)